Isotope dilution--mass spectrometric quantification of specific proteins: model application with apolipoprotein A-I.

An enzymatic hydrolysis isotope dilution-mass spectrometric method was developed for reference quantification of specific proteins. The analytical procedure involved measuring a reproducibly hydrolyzed peptide (serving as the primary standard) unique to a specific protein. This new mass spectrometric method was evaluated by assessing the concentration of apolipoprotein (apo) A-I in the European Community Bureau of Reference (BCR) lyophilized Certified Reference Material (CRM 393). We used the method to make 96 measurements (4 replicate analyses of 4 enzymatic digests of 6 vials of BCR-CRM 393), which gave an average total protein mass of 1.048 mg (+/- 1.0% at 99% confidence limits). The total overall analytical CV was 3.95%. The results of this evaluation of our model approach to determine the concentration of a specific protein in a purified preparation demonstrated that our new mass spectrometric method can be used to measure apolipoproteins and other specific proteins without the use of epitopic immunoassay methods.

[1]  M. Rennie,et al.  Nitrogen estimation in biological samples by use of chemiluminescence. , 1980, Clinical chemistry.

[2]  E. Sampson,et al.  Determination of steroid hormones in a human-serum reference material by isotope dilution--mass spectrometry: a candidate definitive method for cortisol. , 1984, Clinical chemistry.

[3]  L L Needham,et al.  High-resolution gas chromatographic/high-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1987, Analytical chemistry.

[4]  S. Marcovina,et al.  Standardization of apolipoprotein B and A-I measurements. , 1989, Clinical chemistry.

[5]  L. Curtiss,et al.  Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100. , 1989, Journal of lipid research.

[6]  D. Rader,et al.  Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. , 1993, Journal of lipid research.

[7]  A. Scanu,et al.  Soluble and immobilized trypsin as structural probes of human plasma high-density lipoproteins: enzyme properties and kinetics of proteolysis. , 1983, Biochemistry.

[8]  C. Dass,et al.  Characterization of beta-endorphin in human pituitary by fast atom bombardment mass spectrometry of trypsin-generated fragments. , 2009, International journal of peptide and protein research.

[9]  S. J. Smith,et al.  International survey of apolipoproteins A1 and B measurements (1983-1984). , 1985, Clinical chemistry.

[10]  R W Sweet,et al.  Protein and carbohydrate structural analysis of a recombinant soluble CD4 receptor by mass spectrometry. , 1989, The Journal of biological chemistry.

[11]  S. J. Smith,et al.  An international collaborative study on standardization of apolipoproteins A-I and B. Part I. Evaluation of a lyophilized candidate reference and calibration material. , 1987, Clinical chemistry.

[12]  S. Shapiro,et al.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[14]  A. Zinsmeister,et al.  Apolipoproteins and coronary artery disease. , 1986, Mayo Clinic proceedings.

[15]  G L Myers,et al.  Establishment of Reference Methods for Lipids, Lipoproteins and Apolipoproteins , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[16]  P. Bachorik,et al.  Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[17]  S. J. Smith,et al.  Impact of protein measurements on standardization of assays of apolipoproteins A-I and B1. , 1990, Clinical chemistry.

[18]  G. Cazzolato,et al.  Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. , 1980, Atherosclerosis.

[19]  J. Shabanowitz,et al.  Mass spectrometry of proteins and peptides: sensitive and accurate mass measurement and sequence analysis. , 1993, Clinical chemistry.

[20]  B. Chait,et al.  Weighing naked proteins: practical, high-accuracy mass measurement of peptides and proteins. , 1992, Science.

[21]  L. Chan,et al.  Nucleotide sequence of cloned cDNA of human apolipoprotein A-I. , 1983, Nucleic Acids Research.

[22]  B. Chait,et al.  Electrospray ionization mass spectrometric peptide mapping: a rapid, sensitive technique for protein structure analysis. , 1990, Biochemical and biophysical research communications.

[23]  J. Mandel,et al.  Total serum cholesterol by isotope dilution/mass spectrometry: a candidate definitive method. , 1980, Clinical chemistry.

[24]  F. Dati,et al.  International Federation of Clinical Chemistry standardization project for measurements of apolipoproteins A-I and B. , 1991, Clinical chemistry.

[25]  Y. Marcel,et al.  Apolipoprotein A-I assayed in human serum by isotope dilution as a potential standard for immunoassay. , 1988, Journal of lipid research.

[26]  W. Riesen,et al.  Apoproteins and lipids as discriminators of severity of coronary heart disease. , 1980, Atherosclerosis.

[27]  J. Albers,et al.  Comparison of commercial kits for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center. , 1988, Journal of lipid research.